Profile for South Korea Patent: 20200035480
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 20200035480
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,570,391 | Nov 16, 2032 | Alnylam Pharms Inc | AMVUTTRA | vutrisiran sodium |
| 9,399,775 | Nov 16, 2032 | Alnylam Pharms Inc | AMVUTTRA | vutrisiran sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
